Lawsuits Being Prepared Over Omontys Recall

Lawsuits Being Prepared Over Omontys Recall

By Kimberly Mirando

A Class I recall of the anemia drug Omontys (peginesatide) has many kidney dialysis patients and their families wondering if they have a case to file a product liability lawsuit against the suppliers of the drug. The medication has been linked to severe and sometimes fatal allergic reactions.

The U.S. Food and Drug Administration announced the Omontys recall on February 23, 2013, nearly a year after it was approved for the treatment of anemia in adult dialysis patients with chronic kidney disease.  At the time of the recall, the FDA had received 19 reports of anaphylaxis from U.S. dialysis centers, three of which resulted in death. Some patients were able to be resuscitated by doctors, the FDA said.

• Anaphylaxis
• Heart Attack
• Stroke
• Metabolic Alkalosis
• Low Blood Pressure
• Cardiopulmonary Arrest
• Cardiac Arrhythmia
• Rash
• Hives
• Throat or tongue swelling
• Nausea, vomiting or diarrhea

Omontys Lawsuit Settlement

If you or a loved one experienced a severe allergic reaction after being injected with the anemia medication Omontys, you may have a legal claim.

Patient advocates are preparing to file lawsuits and class action lawsuits on behalf of kidney dialysis patients and their families. Compensation is available for pain and suffering, medical expenses, wrongful death, and more.

To find out if you have a case, visit the Omontys Recall Class Action Lawsuit Investigation. Simply fill out the short contact form and an experienced drug injury attorney will review your information for free. The lawyers working this investigation will work for you on a contingency basis, which means you will pay nothing out of pocket. They do not get paid unless you do. Submit your information now!